Daiwa Securities Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16
| Closed | -$1K | – | 1392 |
|
|
2023
Q3 | $1K | Hold |
16
| – | – | ﹤0.01% | 1275 |
|
|
2023
Q2 | $1K | Hold |
16
| – | – | ﹤0.01% | 1298 |
|
|
2023
Q1 | $1K | Hold |
16
| – | – | ﹤0.01% | 1278 |
|
|
2022
Q4 | $2K | Buy |
16
+6
| +60% | +$750 | ﹤0.01% | 1236 |
|
|
2022
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 1245 |
|
|
2022
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1316 |
|
|
2022
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 1267 |
|
|
2021
Q4 | $3K | Hold |
10
| – | – | ﹤0.01% | 1253 |
|
|
2021
Q3 | $6K | Buy |
10
+5
| +100% | +$3K | ﹤0.01% | 1166 |
|
|
2021
Q2 | $2K | Hold |
5
| – | – | ﹤0.01% | 1157 |
|
|
2021
Q1 | $3K | Hold |
5
| – | – | ﹤0.01% | 1123 |
|
|
2020
Q4 | $5K | Buy |
+5
| New | +$5K | ﹤0.01% | 1058 |
|